The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 03, 2012

Filed:

Mar. 06, 2007
Applicants:

Ann Fournillier, Lyon, FR;

Genevieve Inchauspe, Lyon, FR;

Laurence Chatel, Jozier, FR;

Francois Penin, Decines, FR;

Inventors:

Ann Fournillier, Lyon, FR;

Genevieve Inchauspe, Lyon, FR;

Laurence Chatel, Jozier, FR;

Francois Penin, Decines, FR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/29 (2006.01); C12N 7/00 (2006.01); N12N 5/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to an isolated fusion protein comprising at least three NS polypeptides originating from a hepatitis C virus which are configured in said fusion protein in an order which is distinct of the order in which they appear in the native configuration. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof for treating or preventing HCV infections, HCV-associated diseases and pathologic conditions as well as a method of inducing or stimulating an immune response against HCV in a host organism.


Find Patent Forward Citations

Loading…